Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

World

16 Sep, 2024

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage


A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a...

PD-1 and PD-L1 Inhibitor Market Booming: A $100 Billion Industry by 2028?

Business

20 Aug, 2024

PD-1 and PD-L1 Inhibitor Market Booming: A $100 Billion Industry by 2028?


The fight against cancer has entered a new era, marked by the emergence of innovative therapies that target the immune...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates